Fibrin-degradation products in cerebral malaria.
D000293:Adolescent; D000328:Adult; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D002561:Cerebrovascular Disorders / Q000209:etiology*; D002675:Child, Preschool; D002738:Chloroquine / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000209:etiology*; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006400:Hematocrit; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008288:Malaria / Q000097:blood* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D010963:Plasmodium falciparum
D003907:Dexamethasone; D002738:Chloroquine; D005165:Factor V; D005167:Factor VII; D005170:Factor X; D005340:Fibrinogen; D010958:Plasminogen